Loading clinical trials...
Loading clinical trials...
Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
Collaborators
NCT06387615 · Dyslexia, Dyslexia, Developmental, and more
NCT04287530 · Dyslexia, Developmental
NCT04028310 · Dyslexia, Developmental
NCT04122820 · Specific Developmental Disorders of Speech and Language, Specific Learning Disorder, and more
Stanford University
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions